-
Product Insights
NewSerine Protein Kinase ATM – Drugs In Development, 2024
The Serine Protein Kinase ATM pipeline drugs market research report outlays comprehensive information on the Serine Protein Kinase ATM targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Glioblastoma Multiforme (GBM). It also reviews key players involved in Serine Protein Kinase ATM targeted therapeutics development with respective active and dormant...
-
Product Insights
NewOrnithine Carbamoyltransferase Mitochondrial – Drugs In Development, 2024
The Ornithine Carbamoyltransferase Mitochondrial pipeline drugs market research report outlays comprehensive information on the Ornithine Carbamoyltransferase Mitochondrial targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Ornithine-Transcarbamylase Deficiency. It also reviews key players involved in Ornithine Carbamoyltransferase Mitochondrial targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...
-
Product Insights
NewProlyl Endopeptidase FAP – Drugs In Development, 2024
The Prolyl Endopeptidase FAP pipeline drugs market research report outlays comprehensive information on the Prolyl Endopeptidase FAP targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Respiratory which include indications of Solid Tumor, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis. It also reviews key players involved in Prolyl Endopeptidase FAP targeted therapeutics development with respective active and...
-
Product Insights
NewAurora Kinase B – Drugs In Development, 2024
The Aurora Kinase B pipeline drugs market research report outlays comprehensive information on the Aurora Kinase B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), and Gastric Cancer. It also reviews key players involved in Aurora Kinase B targeted therapeutics development with respective active and...
-
Product Insights
NewCD27 Antigen – Drugs In Development, 2024
The CD27 Antigen pipeline drugs market research report outlays comprehensive information on the CD27 Antigen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Immunology which include indications of Solid Tumor, Unspecified B-Cell Lymphomas, Autoimmune Disorders, and Inflammation. It also reviews key players involved in CD27 Antigen targeted therapeutics development with respective active and dormant or...
-
Product Insights
NewN Sulphoglucosamine Sulphohydrolase – Drugs In Development, 2024
The N Sulphoglucosamine Sulphohydrolase pipeline drugs market research report outlays comprehensive information on the N Sulphoglucosamine Sulphohydrolase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ). It also reviews key players involved in N Sulphoglucosamine Sulphohydrolase targeted therapeutics development with respective active and dormant or...
-
Product Insights
NewGTPase NRas – Drugs In Development, 2024
The GTPase NRas pipeline drugs market research report outlays comprehensive information on the GTPase NRas targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Non-Small Cell Lung Cancer. It also reviews key players involved in GTPase NRas targeted therapeutics development with respective active and dormant or discontinued projects. Note: *...
-
Product Insights
NewWerner Syndrome ATP Dependent Helicase – Drugs In Development, 2024
The Werner Syndrome ATP Dependent Helicase pipeline drugs market research report outlays comprehensive information on the Werner Syndrome ATP Dependent Helicase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Unspecified Cancer, and Solid Tumor. It also reviews key players involved in Werner Syndrome ATP Dependent Helicase targeted therapeutics development with respective active...
-
Product Insights
NewCyclin Dependent Kinase 1 – Drugs In Development, 2024
The Cyclin Dependent Kinase 1 pipeline drugs market research report outlays comprehensive information on the Cyclin Dependent Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Mantle Cell Lymphoma. It also reviews key players involved in Cyclin Dependent Kinase 1 targeted therapeutics development with respective active and dormant...
-
Product Insights
NewMonoglyceride Lipase – Drugs In Development, 2024
The Monoglyceride Lipase pipeline drugs market research report outlays comprehensive information on the Monoglyceride Lipase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System which include indications of Substance (Drug) Abuse, and Unspecified Neurologic Disorders. It also reviews key players involved in Monoglyceride Lipase targeted therapeutics development with respective active and dormant or discontinued projects....